T lymphocyte surface antigens — Drug Target

All drugs that target T lymphocyte surface antigens — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Antithymocyte globulin (ATG)

Phase 3 pipeline (1)

• Lapine T-Lymphocyte Immune Globulin · M.D. Anderson Cancer Center · Antithymocyte globulin (ATG) · Immunology, Hematology, Transplantation
  Lapine T-lymphocyte immune globulin depletes T lymphocytes to suppress immune rejection and graft-versus-host disease.